In an experiment carried out in rats, chronic administration of melatonin prevented obesity to a greater extent than acute treatment and reduced visceral obesity by around 3%.
Melatonin prevents kidney damage caused by metabolic complications of obesity
Scientists from the University of Granada (UGR), the Hospital Universitario La Paz (Madrid), and the University of Texas (USA) have taken an important step in the fight against kidney damage and its progression towards kidney failure, which is closely related to diabesity (obesity and its type 2 diabetes) and its complications.
Specifically, in two new studies recently published in the prestigious scientific journals «Journal of Clinical Medicine» and «Pharmaceuticals», researchers have developed it in an obese and diabetic rodent model, and have shown that melatonin protects the kidney damage caused by diabesity.